MDL | MFCD01861511 |
---|---|
Molecular Weight | 190.24 |
Molecular Formula | C12H14O2 |
SMILES | O=C1O/C(C2=C1C=CCC2)=C\CCC |
Pretreatment with Ligustilide (1 μM, 5 μM, 15 μM) significantly improves cell viability. The apoptosis rate in glutamate-induced PC12 cells is 13.39%, and decreased in the presence of Ligustilide (1 μM, 5 μM, 15 μM) by 9.06%, 6.48%, 3.82%, separately. Extracellular accumulation of Ca 2+ induced by glutamate are significantly reduced by Ligustilide. Pretreatment Ligustilide could decrease the release of cytochrome C from mitochondria, down-regulate Caspase-3 protein expression and up-regulate Bcl-2/Bax ratio, thereby protects PC12 cells from apoptosis [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Liquid
Room temperature in continental US; may vary elsewhere.
-20°C, protect from light, stored under nitrogen
* The compound is unstable in solutions, freshly prepared is recommended.
DMSO : 100 mg/mL ( 525.65 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 5.2565 mL | 26.2826 mL | 52.5652 mL |
5 mM | 1.0513 mL | 5.2565 mL | 10.5130 mL |
10 mM | 0.5257 mL | 2.6283 mL | 5.2565 mL |